TVTY Tivity Health Inc.

FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Tivity Health, Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Middle District of Tennessee on behalf of purchasers of Tivity Health, Inc. (NASDAQ: TVTY) (“Tivity” or the “Company”) securities during the period between February 24, 2017 and November 3, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until January 19, 2018 to seek appointment as lead plaintiff.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Tivity securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that Tivity was aware that its customer, United Healthcare, Inc. (“United Healthcare”), planned to expand its fitness benefit to seniors and the expansion would represent direct competition to Tivity’s core program SilverSneaker.

According to the complaint, following a November 6, 2017 press release from United Healthcare announcing expansion of its fitness benefits, the value of Tivity shares declined significantly.

If you have suffered a loss in excess of $100,000 from investment in Tivity securities purchased on or after February 24, 2017 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/casesandinvestigations.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.

EN
09/01/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tivity Health Inc.

Moody's says Tivity Health's ratings unchanged following announcement ...

Moody's Investors Service ("Moody's") said Tivity Health, Inc.'s ("Tivity Health") B2 Corporate Family Rating, B2-PD Probability of Default Rating and B2 ratings of the senior secured bank credit facility, consisting a revolver and a term loan B, are unchanged following the company's announcement on...

TIVITY HEALTH reduced its risk exposure resulting in an upgrade to Sli...

TIVITY HEALTH (US), a company active in the Health Care Providers industry, reduced its market risk and raised its general evaluation. The independent financial analyst theScreener awarded an improved star rating to the company, which now shows 3 out of 4 possible stars; its market behaviour has improved and can be considered as defensive. theScreener believes that this new assessment merits an overall rating upgrade to Slightly Positive. As of the analysis date April 1, 2022, the closing price ...

Tivity Health, Inc.: Update to credit analysis

Our credit view of Tivity Health reflects its solid credit metrics including modest financial leverage, against business and customer concentration risks

Moody's announces completion of a periodic review of ratings of Tivity...

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Tivity Health, Inc.. Global Credit Research- 11 Jan 2022. New York, January 11, 2022-- Moody's Investors Service has completed a periodic review of the ratings of Tivity Health, Inc. and other ratings that are associated with the same analytical unit.

Tivity Health Inc: 1 director

A director at Tivity Health Inc sold 36,810 shares at 27.090USD and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch